We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$720M
AUM Growth
-$49.3M
Cap. Flow
-$18.3M
Cap. Flow %
-2.54%
Top 10 Hldgs %
45.97%
Holding
78
New
15
Increased
29
Reduced
15
Closed
5

Top Buys

Rank Stock Value
1
ELGX
Endologix Inc
ELGX
+$16.8M
2
AGIO icon
Agios Pharmaceuticals
AGIO
+$13.2M
3
RARE icon
Ultragenyx Pharmaceutical
RARE
+$11.5M
4
SIBN icon
SI-BONE Inc
SIBN
+$11.2M
5
CDXS icon
Codexis
CDXS
+$9.29M

Top Sells

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$28.3M
2
IONS icon
Ionis Pharmaceuticals
IONS
+$20.1M
3
HBIO icon
Harvard Bioscience
HBIO
+$19M
4
OMCL icon
Omnicell
OMCL
+$15.5M
5
DVAX
Dynavax Technologies
DVAX
+$12.5M

Sector Composition

Rank Sector Weight
1 Healthcare 74.38%
2 Communication Services 5.9%
3 Financials 0.98%
4 Energy 0.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
26
Teva Pharmaceuticals
TEVA
$40.8B
$8.97M 1.25%
972,234
+659,351
+211% +$7.95M
TNDM icon
27
Tandem Diabetes Care
TNDM
$1.34B
$8.83M 1.23%
136,865
-131,089
-49% -$8.46M
CSII
28
DELISTED
Cardiovascular Systems, Inc.
CSII
$8.12M 1.13%
189,032
+921
+0.5% +$35.7K
BMY icon
29
Bristol-Myers Squibb
BMY
$133B
$7.5M 1.04%
+165,397
New +$7.7M
TAK icon
30
Takeda Pharmaceutical
TAK
$54.6B
$7.34M 1.02%
414,627
+1,491
+0.4% +$27.1K
SLP icon
31
Simulations Plus
SLP
$369M
$7.24M 1.01%
253,530
+1,221
+0.5% +$29.6K
TRUP icon
32
Trupanion
TRUP
$1.07B
$7.04M 0.98%
194,778
+958
+0.5% +$31.5K
LHCG
33
DELISTED
LHC Group LLC
LHCG
$6.46M 0.9%
54,053
+270
+0.5% +$30.4K
BMRN icon
34
BioMarin Pharmaceuticals
BMRN
$11.6B
$6M 0.83%
70,077
+4,417
+7% +$378K
TECH icon
35
Bio-Techne
TECH
$11.2B
$5.94M 0.82%
113,964
+6,700
+6% +$338K
KDNY
36
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$5.57M 0.77%
723,531
+1,197
+0.2% +$18.2K
ALKS icon
37
Alkermes
ALKS
$8.22B
$5.14M 0.71%
228,023
+16,859
+8% +$462K
VRTX icon
38
Vertex Pharmaceuticals
VRTX
$121B
$4.93M 0.68%
26,878
+119
+0.4% +$20.8K
KIDS icon
39
OrthoPediatrics
KIDS
$519M
$4.81M 0.67%
123,260
+611
+0.5% +$24.6K
NVTR
40
DELISTED
Nuvectra Corporation Common Stock
NVTR
$4.48M 0.62%
1,338,092
+25
+0% +$158
ALXN
41
DELISTED
Alexion Pharmaceuticals
ALXN
$3.53M 0.49%
+26,920
New +$3.47M
QDEL icon
42
QuidelOrtho
QDEL
$1.14B
$3.26M 0.45%
54,943
+268
+0.5% +$16.1K
ARNA
43
DELISTED
Arena Pharmaceuticals Inc
ARNA
$2.62M 0.36%
+44,704
New +$2.31M
EPZM
44
DELISTED
Epizyme, Inc
EPZM
$2.51M 0.35%
+200,063
New +$2.57M
BLUE
45
DELISTED
bluebird bio
BLUE
$2.4M 0.33%
1,454
+8
+0.6% +$13.8K
HSTM icon
46
HealthStream
HSTM
$819M
$2.35M 0.33%
90,924
+386
+0.4% +$10.1K
IBB icon
47
iShares Biotechnology ETF
IBB
$9.34B
$2.32M 0.32%
21,248
– –
PSCH icon
48
Invesco S&P SmallCap Health Care ETF
PSCH
$163M
$2.04M 0.28%
+51,855
New +$1.96M
TLGT
49
DELISTED
Teligent, Inc
TLGT
$2.03M 0.28%
322,700
+171,382
+113% +$1.4M
IHI icon
50
iShares US Medical Devices ETF
IHI
$3.13B
$1.82M 0.25%
45,480
– –
1
2
3 4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, First Light Asset Management held 78 positions worth $720M, down 6.4% from $770M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

First Light Asset Management's Q2 2019 filing shows 15 new, 29 increased, 15 reduced and 5 closed positions. Its largest new stake was Endologix Inc: 2,462,448 shares worth $17.8M. The largest sale was Array Biopharma Inc, an estimated $28.3M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 75% a quarter earlier, followed by Communication Services and Financials.

  • First Light Asset Management's largest Q2 2019 buy was Endologix Inc: 2,462,448 shares worth $17.8M.
  • First Light Asset Management added most to Codexis in Q2 2019, an estimated $9.29M increase.
  • First Light Asset Management's biggest Q2 2019 reduction was Array Biopharma Inc, cutting an estimated $28.3M.
  • First Light Asset Management fully exited Dynavax Technologies in Q2 2019, selling an estimated $12.5M.
  • First Light Asset Management's ten largest holdings make up 46% of its $720M portfolio in Q2 2019.
  • First Light Asset Management opened 15 new positions and closed 5 in Q2 2019.
  • First Light Asset Management's portfolio value fell 6.4% quarter-over-quarter to $720M.

Based on First Light Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.